Publication:
Reliability and Validity of the Turkish Translation of the PedsQL™ 3.0 Neuromuscular Module for 2-to 4-Year-Olds in Spinal Muscular Atrophy.

dc.contributor.authorKutlutürk Yikilmaz S.
dc.contributor.authorTANRIVERDİ M.
dc.contributor.authorOKTEM S.
dc.contributor.institutionauthorTANRIVERDİ, MÜBERRA
dc.date.accessioned2024-04-28T21:50:15Z
dc.date.available2024-04-28T21:50:15Z
dc.date.issued2024-04-08
dc.description.abstractBackground: The Pediatric Quality of Life InventoryTM Neuromuscular Module (PedsQLTM 3.0 NM) evaluates the health-related quality of life in children who are affected by neuromuscular diseases. This study’s aim is to assess the adaptation of the PedsQLTM 3.0 NM Turkish version (PedsQLTM 3.0 NM-TR) for 2-4 years old in spinal muscular atrophy (SMA). Methods: The procedure of translating the PedsQLTM 3.0 NM into Turkish was conducted in accordance with the translation methodology outlined by the PedsQLTM measurement model. The PedsQLTM 3.0 NM-TR was administered to 54 parents of children with SMA aged 2-4 years. The test-retest reliability and intraclass correlation coefficient (ICC) were measured for reliability analysis. Cronbach\"s alpha coefficient and item score correlations were calculated for internal consistency. Concurrent construct validity was evaluated by Pearson correlations between the outcomes of the PedsQLTM 4.0 Generic Core Scale (PedsQLTM 4.0 GCS) and the PedsQLTM 3.0 NM. Results: The PedsQLTM 3.0 NM-TR total score shows excellent reliability. The Cronbach\"s alpha values for the PedsQLTM 3.0 NM ranged between 0.871-0.906, while those for the PedsQLTM 4.0 GCS ranged 0.843-0.897. Test-retest ICC values for the PedsQLTM 3.0 NM-TR ranged 0.812-0.917, and for the PedsQLTM 4.0 GCS ranged 0.773-0.899. The relationship between the PedsQLTM 3.0 NM-TR and the subscores of the PedsQLTM 4.0 GCS demonstrated a range of correlations from excellent to fair, indicating the interplay between two scales. Conclusions: This study established the PedsQLTM 3.0 NM-TR as reliable, valid, and feasible for use in children aged 2-4 years old with SMA.
dc.identifier.citationKutlutürk Yikilmaz S., TANRIVERDİ M., OKTEM S., "Reliability and Validity of the Turkish Translation of the PedsQL™ 3.0 Neuromuscular Module for 2-to 4-Year-Olds in Spinal Muscular Atrophy.", Neuropediatrics, 2024
dc.identifier.doi10.1055/a-2288-6383
dc.identifier.issn0174-304X
dc.identifier.pubmed38490253
dc.identifier.scopus85188191095
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85188191095&origin=inward
dc.identifier.urihttps://hdl.handle.net/20.500.12645/39240
dc.identifier.wosWOS:001198351400001
dc.relation.ispartofNeuropediatrics
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectNöroloji
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectChild Health and Diseases
dc.subjectNeurology
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectPEDİATRİ
dc.subjectKLİNİK NÖROLOJİ
dc.subjectClinical Medicine (MED)
dc.subjectCLINICAL MEDICINE
dc.subjectPEDIATRICS
dc.subjectCLINICAL NEUROLOGY
dc.subjectPediatri, Perinatoloji ve Çocuk Sağlığı
dc.subjectNöroloji (klinik)
dc.subjectPediatrics, Perinatology and Child Health
dc.subjectNeurology (clinical)
dc.subjectChild
dc.subjectNeuromuscular diseases
dc.subjectQuality of life
dc.subjectSpinal muscular atrophy
dc.subjectTurkish
dc.titleReliability and Validity of the Turkish Translation of the PedsQL™ 3.0 Neuromuscular Module for 2-to 4-Year-Olds in Spinal Muscular Atrophy.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id566f009f-4891-4c57-9290-81516f91ce96
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublication684e67c7-883b-48d4-8062-66e056a0c6b5
relation.isAuthorOfPublication.latestForDiscovery684e67c7-883b-48d4-8062-66e056a0c6b5

Files